Total Payments
$14,496
2024 Payments
$4,515
Companies
51
Transactions
862
Medicare Patients
2,299
Medicare Billing
$231,068
Payment Breakdown by Category
Food & Beverage$14,092 (97.2%)
Education$404.36 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,092 | 854 | 97.2% |
| Education | $404.36 | 8 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,561 | 99 | $0 (2024) |
| UCB, Inc. | $1,209 | 54 | $0 (2024) |
| ABBVIE INC. | $1,201 | 112 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $791.56 | 24 | $0 (2024) |
| PFIZER INC. | $680.27 | 54 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $642.89 | 27 | $0 (2024) |
| MDD US Operations, LLC | $625.98 | 15 | $0 (2024) |
| EMD Serono, Inc. | $587.12 | 48 | $0 (2024) |
| Lilly USA, LLC | $462.11 | 32 | $0 (2024) |
| Amgen Inc. | $453.11 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,515 | 230 | UCB, Inc. ($585.07) |
| 2023 | $4,348 | 269 | Biogen, Inc. ($512.36) |
| 2022 | $3,924 | 249 | Biogen, Inc. ($513.77) |
| 2021 | $1,479 | 86 | Biogen, Inc. ($378.28) |
| 2019 | $230.48 | 28 | EMD Serono, Inc. ($190.42) |
All Payment Transactions
862 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: PAIN | ||||||
| 12/17/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.55 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Neurology | ||||||
| 11/26/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $11.28 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 861 | 1,226 | $207,132 | $74,559 |
| 2022 | 17 | 1,132 | 1,673 | $308,177 | $121,714 |
| 2021 | 12 | 306 | 583 | $77,840 | $34,794 |
Total Patients
2,299
Total Services
3,482
Medicare Billing
$231,068
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 162 | 184 | $22,502 | $13,548 | 60.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 96 | $23,040 | $9,368 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 128 | $22,556 | $9,136 | 40.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 112 | $14,504 | $6,674 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 60 | 60 | $12,774 | $6,075 | 47.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 56 | $13,720 | $5,782 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $12,679 | $3,900 | 30.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 16 | 16 | $8,768 | $3,860 | 44.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 87 | 93 | $12,980 | $3,860 | 29.7% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 14 | 16 | $30,752 | $3,727 | 12.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,150 | $2,195 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 37 | $2,922 | $1,827 | 62.5% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 13 | 13 | $13,845 | $1,536 | 11.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 40 | $3,840 | $1,533 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $3,240 | $1,430 | 44.1% |
| 82565 | Blood creatinine level | Office | 2023 | 13 | 15 | $270.00 | $75.30 | 27.9% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 14 | 265 | $1,590 | $32.44 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 210 | $36,750 | $19,282 | 52.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 117 | 117 | $38,025 | $16,985 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 122 | $24,715 | $15,100 | 61.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 143 | 146 | $31,185 | $15,067 | 48.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 180 | $29,910 | $14,163 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $26,610 | $10,398 | 39.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 29 | 29 | $15,458 | $7,570 | 49.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 114 | 121 | $13,794 | $5,319 | 38.6% |
About Jae Eun Lee
Jae Eun Lee is a Neurology healthcare provider based in Bowling Green, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1346622792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jae Eun Lee has received a total of $14,496 in payments from pharmaceutical and medical device companies, with $4,515 received in 2024. These payments were reported across 862 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($14,092).
As a Medicare-enrolled provider, Lee has provided services to 2,299 Medicare beneficiaries, totaling 3,482 services with total Medicare billing of $231,068. Data is available for 3 years (2021–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Bowling Green, KY
- Active Since 06/22/2015
- Last Updated 08/03/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1346622792
Products in Payments
- NURTEC ODT (Drug) $923.86
- UBRELVY (Drug) $713.55
- TYSABRI (Biological) $602.23
- VUMERITY (Drug) $523.51
- Gocovri (Drug) $520.14
- INGREZZA (Drug) $512.81
- Nayzilam (Drug) $507.31
- Briviact (Drug) $483.05
- Aimovig (Biological) $453.11
- VYEPTI (Biological) $349.09
- VALTOCO (Drug) $347.44
- KESIMPTA (Drug) $341.85
- EMGALITY (Drug) $329.78
- ULTOMIRIS (Biological) $310.53
- EPIDIOLEX (Drug) $281.90
- Hizentra (Biological) $274.10
- QULIPTA (Drug) $261.03
- RYTARY (Drug) $259.46
- ACTHAR (Biological) $258.89
- APTIOM (Drug) $252.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bowling Green
Dr. Jianhua Zhu, M.d, M.D
Neurology — Payments: $30,403
Neurology $30,403
Dr. Wesley Chou, M.d, M.D
Neurology — Payments: $28,112
Neurology $28,112
Xue Yang, Md, Phd, MD, PHD
Neurology — Payments: $3,616
Neurology $3,616
Haroon Majoka, M.d, M.D
Neurology — Payments: $3,395
Neurology $3,395
Dr. Amir Zia, M.d, M.D
Neurology — Payments: $2,784
Neurology $2,784
Dr. Dennis O'keefe, M.d, M.D
Neurology — Payments: $362.73
Neurology $362.73